Sirolimus eluting stent (Cypher™) in patients with diabetes mellitus: results from the German Cypher Stent Registry

2007 ◽  
Vol 97 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Frank D. Weber ◽  
Henrik Schneider ◽  
Marcus Wiemer ◽  
Thomas Pfannebecker ◽  
Ulrich Tebbe ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Patients With Diabetes ◽  
Sirolimus Eluting Stent

scholarly journals Randomized Comparison of a Polymer-Free Sirolimus-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent in Patients With Diabetes Mellitus

2011 ◽  
Vol 4 (4) ◽  
pp. 452-459 ◽  
Author(s):  
Steffen Desch ◽  
Denis Schloma ◽  
Sven Möbius-Winkler ◽  
Sandra Erbs ◽  
Stephan Gielen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Patients With Diabetes ◽  
Sirolimus Eluting Stent

Abluminus DES+ for the treatment of coronary artery disease in patients with diabetes mellitus

2020 ◽  
Author(s):  
Ridhima Goel ◽  
Rishi Chandiramani ◽  
Roxana Mehran
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Clinical Outcomes ◽  
Coronary Intervention ◽  
World Population ◽  
Global Epidemic ◽  
Patients With Diabetes ◽  
Artery Disease ◽  
Sirolimus Eluting Stent

Diabetes mellitus (DM) is a rising global epidemic affecting more than 10% of the world population and predisposes patients to develop highly progressive and complex coronary artery disease. Despite numerous advancements in percutaneous coronary intervention procedural techniques and coronary stent platforms, clinical outcomes in DM patients have improved little compared with non-DM patients. Abluminus DES+, a biodegradable polymer sirolimus-eluting stent deployed with a drug-coated balloon, has been specifically designed to provide adequate coverage for DM patients and reduce adverse clinical outcomes.

Sign in / Sign up

Export Citation Format

Share Document